iCamuno starts with induced pluripotent stem cells (iPSCs) and uses cutting-edge technologies such as gene editing, and algorithm-driven cellular differentiation to empower cells. Guided by the philosophy of “demand-oriented, patient-centered”, we are changing the face of tumor immunotherapy and reg...See more
Headquarters:
China
Company Type:
SME
Company size:
51-200 Employees
Year Founded:
2021 (5 years)
Address:
苏州, CN
HIGH
spending power